The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); Novartis (Inst)
Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Final analysis of a phase II trial.
 
Haeseong Park
Research Funding - Ambrx (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); BJ Bioscience (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Gossamer Bio (Inst); ImmuneOncia (Inst); Immunomedics (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Lilly (Inst); MabSpace Biosciences (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncologie (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Synermore Biologics (Inst); Taiho Pharmaceutical (Inst); Top Alliance BioScience (Inst); Turning Point Therapeutics (Inst); Vedanta Biosciences (Inst); Vertex (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bayer; Daiichi Sankyo; Vedanta Biosciences
 
Aravind Sanjeevaiah
Consulting or Advisory Role - Legend Biotech; Legend Biotech
Travel, Accommodations, Expenses - NanoCarrier
 
Peter Joel Hosein
Research Funding - Agenus (Inst); AngioDynamics (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Eisai (Inst); NGM Biopharmaceuticals (Inst)
 
Rutika Mehta
Honoraria - Bristol-Myers Squibb; NCCN; NCCN/Pfizer (I); Pfizer/EMD Serono (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Lilly
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences (I); Natera; Seagen (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ramon Jin
No Relationships to Disclose
 
Patrick Grierson
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer
 
Rama Suresh
No Relationships to Disclose
 
Olivia Aranha
Research Funding - Ipsen (Inst); Merck (Inst); Pfizer (Inst)
 
Nikolaos A. Trikalinos
No Relationships to Disclose
 
Nusayba Ali Bagegni
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Lilly (Inst); Novartis (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst); Xcovery (Inst)
 
Katrina Sophia Pedersen
Consulting or Advisory Role - Array BioPharma; Bayer; Pfizer
Speakers' Bureau - Clinical Care Options
Research Funding - Abbvie (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Ipsen (Inst); Merck (Inst); Natera (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; Nouscom
 
Kian-Huat Lim
Honoraria - Jacobio
Research Funding - Aclaris Therapeutics
 
Andrew B. Nixon
Consulting or Advisory Role - AdjuVolt; GlaxoSmithKline; Leap Therapeutics; Lilly; Promega
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); HTG Molecular Diagnostics (Inst); medpacto (Inst); OncoMed (Inst); Promega (Inst); Seagen (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Jason Mills
No Relationships to Disclose
 
Ryan Fields
No Relationships to Disclose
 
Benjamin R. Tan
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); Roche/Genentech (Inst); Sillajen (Inst); tyrogenex (Inst)
 
Jingxia Liu
No Relationships to Disclose
 
Amberly Brown
No Relationships to Disclose
 
Andrea wang-gillam
Employment - Jacobio
Stock and Other Ownership Interests - Jacobio
Consulting or Advisory Role - AstraZeneca; Bayer; Inxmed; Merck
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Lilly (Inst); Merck (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
A. Craig Lockhart
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst)